Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 39
Filtrer
Plus de filtres











Gamme d'année
1.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;48(2): 140-145, 02/2015. tab, graf
Article de Anglais | LILACS | ID: lil-735849

RÉSUMÉ

The present study evaluated electrocardiographic alterations in rats with epilepsy submitted to an acute myocardial infarction (AMI) model induced by cardiac ischemia and reperfusion. Rats were randomly divided into two groups: control (n=12) and epilepsy (n=14). It was found that rats with epilepsy presented a significant reduction in atrioventricular block incidence following the ischemia and reperfusion procedure. In addition, significant alterations were observed in electrocardiogram intervals during the stabilization, ischemia, and reperfusion periods of rats with epilepsy compared to control rats. It was noted that rats with epilepsy presented a significant increase in the QRS interval during the stabilization period in relation to control rats (P<0.01). During the ischemia period, there was an increase in the QRS interval (P<0.05) and a reduction in the P wave and QT intervals (P<0.05 for both) in rats with epilepsy compared to control rats. During the reperfusion period, a significant reduction in the QT interval (P<0.01) was verified in the epilepsy group in relation to the control group. Our results indicate that rats submitted to an epilepsy model induced by pilocarpine presented electrical conductivity alterations of cardiac tissue, mainly during an AMI episode.


Sujet(s)
Bactériophage lambda/physiologie , Escherichia coli/virologie , Protéines virales/métabolisme , Séquence d'acides aminés , Membrane cellulaire/métabolisme , Régulation de l'expression des gènes viraux/physiologie , Données de séquences moléculaires , Protéines virales/génétique , Libération de particules virales/physiologie
2.
Braz J Med Biol Res ; 48(2): 140-5, 2015 Feb.
Article de Anglais | MEDLINE | ID: mdl-25590352

RÉSUMÉ

The present study evaluated electrocardiographic alterations in rats with epilepsy submitted to an acute myocardial infarction (AMI) model induced by cardiac ischemia and reperfusion. Rats were randomly divided into two groups: control (n=12) and epilepsy (n=14). It was found that rats with epilepsy presented a significant reduction in atrioventricular block incidence following the ischemia and reperfusion procedure. In addition, significant alterations were observed in electrocardiogram intervals during the stabilization, ischemia, and reperfusion periods of rats with epilepsy compared to control rats. It was noted that rats with epilepsy presented a significant increase in the QRS interval during the stabilization period in relation to control rats (P<0.01). During the ischemia period, there was an increase in the QRS interval (P<0.05) and a reduction in the P wave and QT intervals (P<0.05 for both) in rats with epilepsy compared to control rats. During the reperfusion period, a significant reduction in the QT interval (P<0.01) was verified in the epilepsy group in relation to the control group. Our results indicate that rats submitted to an epilepsy model induced by pilocarpine presented electrical conductivity alterations of cardiac tissue, mainly during an AMI episode.


Sujet(s)
Électrocardiographie , Épilepsie/complications , Infarctus du myocarde/étiologie , Lésion de reperfusion myocardique/complications , Animaux , Modèles animaux de maladie humaine , Conductivité électrique , Coeur/innervation , Rythme cardiaque , Mâle , Infarctus du myocarde/physiopathologie , Lésion de reperfusion myocardique/physiopathologie , Pilocarpine/administration et posologie , Rat Wistar , Facteurs temps
3.
Transplant Proc ; 44(8): 2300-3, 2012 Oct.
Article de Anglais | MEDLINE | ID: mdl-23026579

RÉSUMÉ

To study whether treatment with heparin (HEP) attenuates intestinal dysfunction caused by ischemia (I) and reperfusion (R), rats were treated with HEP (100 U/kg intravenously) or saline solution (SS) before I (60 min), which was produced by occlusion of the superior mesenteric artery, and R (120 min). After I or I/R, we mounted 2-cm jejunal segment in an organ bath to study neurogenic contractions stimulated by electrical pulses or KCl, using a digital recording system. Thin jejunal slices were stained with hematoxylin and eosin for optical microscopy. Compared with the sham group, jejunal contractions were similar in the I + HEP and the I/R + HEP groups, but reduced in the I + SS and the I/R + SS groups. The jejunal enteric nerves were damaged in the I + SS and the I/R + SS, but not in the I + HEP and the I/R + HEP cohorts. These results suggested that HEP attenuated intestinal dysfunction caused by I and I/R.


Sujet(s)
Agents gastro-intestinaux/pharmacologie , Héparine/pharmacologie , Jéjunum/vascularisation , Jéjunum/effets des médicaments et des substances chimiques , Lésion d'ischémie-reperfusion/prévention et contrôle , Animaux , Cytoprotection , Modèles animaux de maladie humaine , Stimulation électrique , Système nerveux entérique/effets des médicaments et des substances chimiques , Système nerveux entérique/physiopathologie , Motilité gastrointestinale/effets des médicaments et des substances chimiques , Jéjunum/innervation , Jéjunum/anatomopathologie , Jéjunum/physiopathologie , Mâle , Chlorure de potassium/pharmacologie , Rats , Rat Wistar , Lésion d'ischémie-reperfusion/anatomopathologie , Lésion d'ischémie-reperfusion/physiopathologie
4.
Transplant Proc ; 44(8): 2304-8, 2012 Oct.
Article de Anglais | MEDLINE | ID: mdl-23026580

RÉSUMÉ

To study whether ischemic preconditioning (IPC) attenuated intestinal dysfunction caused by ischemia (I) and reperfusion (R), rats were underwent 60 minutes of I which was produced by occlusion of the superior mesenteric artery, and/or 120 minutes R. The IPC group had the I procedure previously stimulated for 5 minutes and the R for 10 minutes. IPC and sham groups were injected with saline solution (SS) via the femoral vein 5 minutes before the I and R, and for R. After I or I/R, 2-cm jejunal segments were mounted in an organ bath to study neurogenic contractions stimulated by electrical pulses or KCl using a digital recording system. Thin jejunal slices were stained with hematoxylin and eosin for optical microscopy. Compared with the sham group, jejunal contractions were similar in the IPC + I and the IPC + I/R groups, but reduced in the I + SS and the I/R + SS groups. The jejunal enteric nerves were damaged in the I + SS and the I/R + SS groups, but not in the IPC groups. These results suggested that ischemic preconditioning attenuated intestinal dysfunction caused by I and I/R.


Sujet(s)
Préconditionnement ischémique , Jéjunum/vascularisation , Lésion d'ischémie-reperfusion/prévention et contrôle , Animaux , Modèles animaux de maladie humaine , Stimulation électrique , Système nerveux entérique/physiopathologie , Motilité gastrointestinale , Jéjunum/effets des médicaments et des substances chimiques , Jéjunum/innervation , Jéjunum/anatomopathologie , Jéjunum/physiopathologie , Mâle , Chlorure de potassium/pharmacologie , Rats , Rat Wistar , Lésion d'ischémie-reperfusion/anatomopathologie , Lésion d'ischémie-reperfusion/physiopathologie
5.
Transplant Proc ; 44(8): 2309-12, 2012 Oct.
Article de Anglais | MEDLINE | ID: mdl-23026581

RÉSUMÉ

To examine whether treatment with L-arginine (ARG), a substrate of nitric oxide biosynthesis, attenuated intestinal dysfunction caused by ischemia (I) and reperfusion (R), we treated rats with ARG (100 mg/kg intravenously) or saline solution (SS) before 60 minutes of I produced by occlusion of the superior mesenteric artery and/or during 120 minutes of R. After I or I/R, we isolated 2-cm jejunal segments for mounting in an organ bath to study neurogenic contractions stimulated by electrical pulses or KCl with the use of a digital recording system. Thin jejunal slices were stained with hematoxylin and eosin for optical microscopy. Jejunal contractions were similar in the sham and I+ARG, but reduced in I+SS, I/R+SS, and I/R+ARG groups. Jejunal enteric nerves were damaged in I+SS, IR+SS, and IR+ARG, but not in the I+ARG group, suggesting that ARG attenuate intestinal dysfunctions due to I but not to R.


Sujet(s)
Arginine/pharmacologie , Agents gastro-intestinaux/pharmacologie , Jéjunum/vascularisation , Jéjunum/effets des médicaments et des substances chimiques , Lésion d'ischémie-reperfusion/traitement médicamenteux , Animaux , Cytoprotection , Modèles animaux de maladie humaine , Stimulation électrique , Système nerveux entérique/effets des médicaments et des substances chimiques , Système nerveux entérique/physiopathologie , Motilité gastrointestinale/effets des médicaments et des substances chimiques , Jéjunum/innervation , Jéjunum/anatomopathologie , Jéjunum/physiopathologie , Mâle , Chlorure de potassium/pharmacologie , Rats , Rat Wistar , Lésion d'ischémie-reperfusion/anatomopathologie , Lésion d'ischémie-reperfusion/physiopathologie
6.
Transplant Proc ; 44(8): 2317-20, 2012 Oct.
Article de Anglais | MEDLINE | ID: mdl-23026583

RÉSUMÉ

To study whether treatment with adenosine (ADO), an agonist of adenosine receptors, attenuates intestinal dysfunction caused by ischemia (I) and reperfusion (R), we treated rats with ADO (15 mg/kg or saline solution (SS) intravenously before 60 minutes occlusion of the superior mesenteric artery (I) and/or 120 minutes after its release (R). After I or I/R, isolated jejunal segments (2 cm) were mounted in an organ bath to study nerve-mediated contractions stimulated by electrical pulses or KCI with the use of a digital recording system. Thin jejunal slices were stained with hematoxylin and eosin for optical microscopy. Compared with the sham group, jejunal contractions were reduced in I+SS and IR+SS but similar after treatment with ADO (I+ADO and IR+ADO groups). We concluded that rat jejunal enteric nerves were damaged in I+SS and IR+SS but not in the I+ADO and IR+ADO groups. These results suggested that ADO attenuated intestinal dysfunction due to I and R.


Sujet(s)
Adénosine/pharmacologie , Agents gastro-intestinaux/pharmacologie , Jéjunum/vascularisation , Jéjunum/effets des médicaments et des substances chimiques , Lésion d'ischémie-reperfusion/prévention et contrôle , Animaux , Cytoprotection , Modèles animaux de maladie humaine , Stimulation électrique , Système nerveux entérique/effets des médicaments et des substances chimiques , Système nerveux entérique/physiopathologie , Motilité gastrointestinale/effets des médicaments et des substances chimiques , Jéjunum/innervation , Jéjunum/anatomopathologie , Jéjunum/physiopathologie , Chlorure de potassium/pharmacologie , Rats , Rat Wistar , Lésion d'ischémie-reperfusion/anatomopathologie , Lésion d'ischémie-reperfusion/physiopathologie
7.
Transplant Proc ; 44(8): 2313-6, 2012 Oct.
Article de Anglais | MEDLINE | ID: mdl-23026582

RÉSUMÉ

To study whether treatment with the beta-blocker atenolol (AT) attenuates intestinal dysfunction caused by ischemia (I) and reperfusion (R), rats were treated with AT (1.5 mg · kg(-1), intravenously) or saline solution (SS) prior to I (60 minutes), which was produced by occlusion of the superior mesenteric artery, and/or R (120 minutes). After I or I/R, 2-cm jejunal segments were mounted in an organ bath to study neurogenic contractions stimulated by electrical pulses or KCl using a digital recording system. Thin jejunal slices were stained with hematoxylin and eosin for optical microscopy analysis. Compared to the sham group, jejunal contractions were similar in the I + AT and the I/R + AT groups, but reduced in the I + SS and the I/R + SS groups. The jejunal enteric nerves were damaged in the I + SS and the I/R + SS groups, but not in the I + AT and the I/R + AT. These results suggest that AT may attenuate intestinal dysfunction caused by I and I/R.


Sujet(s)
Antagonistes des récepteurs bêta-1 adrénergiques/pharmacologie , Aténolol/pharmacologie , Agents gastro-intestinaux/pharmacologie , Jéjunum/vascularisation , Jéjunum/effets des médicaments et des substances chimiques , Lésion d'ischémie-reperfusion/prévention et contrôle , Animaux , Cytoprotection , Modèles animaux de maladie humaine , Stimulation électrique , Système nerveux entérique/effets des médicaments et des substances chimiques , Système nerveux entérique/physiopathologie , Motilité gastrointestinale/effets des médicaments et des substances chimiques , Jéjunum/innervation , Jéjunum/anatomopathologie , Jéjunum/physiopathologie , Mâle , Chlorure de potassium/pharmacologie , Rats , Rat Wistar , Lésion d'ischémie-reperfusion/anatomopathologie , Lésion d'ischémie-reperfusion/physiopathologie
8.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;43(5): 500-505, May 2010. tab, ilus
Article de Anglais | LILACS | ID: lil-546327

RÉSUMÉ

The regulatory function of á1B-adrenoceptors in mammalian heart homeostasis is controversial. The objective of the present study was to characterize the expression/activity of key proteins implicated in cardiac calcium handling (Na+/K+-ATPase and Ca2+-ATPases) and growth (ERK1/2, JNK1/2 and p38) in mice with cardiac-selective overexpression of constitutively active mutant á1B-adrenoceptor (CAMá1B-AR), which present a mild cardiac hypertrophy phenotype. Immunoblot assays showed that myocardial plasma membrane Ca2+-ATPase (PMCA) expression was increased by 30 percent in CAMá1B-AR mice (N = 6, P < 0.05), although there was no change in sarco/endoplasmic reticulum Ca2+-ATPase (SERCA2) expression. Moreover, total Ca2+-ATPase activity was not modified, but a significant increase in the activity of the thapsigargin-resistant (PMCA) to thapsigargin-sensitive (SERCA) ratio was detected. Neither Na+/K+-ATPase activity nor the expression of á1 and á2 subunit isoforms was changed in CAMá1B-AR mouse hearts. Moreover, immunoblot assays did not provide evidence for an enhanced activation of the three mitogen-activated protein kinases studied in this stage of hypertrophy. Therefore, these findings indicate that chronic cardiac á1B-AR activation in vivo led to mild hypertrophy devoid of significant signs of adaptive modifications concerning primary intracellular calcium control and growth-related proteins, suggesting a minor pathophysiological role of this adrenergic receptor in mouse heart at this stage of development.


Sujet(s)
Animaux , Mâle , Souris , Adenosine triphosphatases/métabolisme , Mitogen-Activated Protein Kinases/métabolisme , Myocarde/enzymologie , Récepteurs alpha-1 adrénergiques/métabolisme , Signalisation calcique/physiologie , Souris transgéniques , Régulation positive
9.
Braz J Med Biol Res ; 43(5): 500-5, 2010 May.
Article de Anglais | MEDLINE | ID: mdl-20414585

RÉSUMÉ

The regulatory function of alpha(1B)-adrenoceptors in mammalian heart homeostasis is controversial. The objective of the present study was to characterize the expression/activity of key proteins implicated in cardiac calcium handling (Na(+)/K(+)-ATPase and Ca(2+)-ATPases) and growth (ERK1/2, JNK1/2 and p38) in mice with cardiac-selective overexpression of constitutively active mutant alpha1B-adrenoceptor (CAMalpha(1B)-AR), which present a mild cardiac hypertrophy phenotype. Immunoblot assays showed that myocardial plasma membrane Ca(2+)-ATPase (PMCA) expression was increased by 30% in CAMalpha(1B)-AR mice (N = 6, P < 0.05), although there was no change in sarco/endoplasmic reticulum Ca(2+)-ATPase (SERCA2) expression. Moreover, total Ca(2+)-ATPase activity was not modified, but a significant increase in the activity of the thapsigargin-resistant (PMCA) to thapsigargin-sensitive (SERCA) ratio was detected. Neither Na(+)/K(+)-ATPase activity nor the expression of alpha(1) and alpha(2) subunit isoforms was changed in CAMalpha(1B)-AR mouse hearts. Moreover, immunoblot assays did not provide evidence for an enhanced activation of the three mitogen-activated protein kinases studied in this stage of hypertrophy. Therefore, these findings indicate that chronic cardiac alpha(1B)-AR activation in vivo led to mild hypertrophy devoid of significant signs of adaptive modifications concerning primary intracellular calcium control and growth-related proteins, suggesting a minor pathophysiological role of this adrenergic receptor in mouse heart at this stage of development.


Sujet(s)
Adenosine triphosphatases/métabolisme , Mitogen-Activated Protein Kinases/métabolisme , Myocarde/enzymologie , Récepteurs alpha-1 adrénergiques/métabolisme , Animaux , Signalisation calcique/physiologie , Mâle , Souris , Souris transgéniques , Régulation positive
10.
Transplant Proc ; 42(2): 448-50, 2010 Mar.
Article de Anglais | MEDLINE | ID: mdl-20304161

RÉSUMÉ

To study whether treatment with L-arginine (ARG), a substrate of nitric oxide biosynthesis, attenuates intestinal dysfunction caused by ischemia (I) and reperfusion (R), rabbits treated with ARG (100 mgxkg(-1), intravenously) or saline solution (SS) prior to I (60 minutes) by occlusion of superior mesenteric artery and/or during R (120 minutes). After I or I/R, 2-cm jejunal segments were isolated and mounted in an organ bath to study of neurogenic contractions stimulated by electrical pulses or KCl using a digital recording system. Thin jejunal slices were stained (hematoxylin and eosin) for analysis by optical microscopy. Compared to the sham group, jejunal contractions were similar in I + ARG, but reduced in I + SS, I/R + SS, and I/R + ARG groups. The jejunal enteric nerves were damaged in I + SS, I/R + SS, and I/R + ARG, but not in I + ARG group, suggesting that ARG can attenuate intestinal dysfunctions due to I, but not to R.


Sujet(s)
Arginine/pharmacologie , Intestins/vascularisation , Monoxyde d'azote/biosynthèse , Lésion d'ischémie-reperfusion/prévention et contrôle , Animaux , Arginine/usage thérapeutique , Circulation sanguine , Veine fémorale/physiologie , Motilité gastrointestinale/effets des médicaments et des substances chimiques , Motilité gastrointestinale/physiologie , Ischémie/physiopathologie , Jéjunum/vascularisation , Jéjunum/effets des médicaments et des substances chimiques , Jéjunum/anatomopathologie , Artère mésentérique supérieure/physiologie , Lapins , Reperfusion/effets indésirables , Lésion d'ischémie-reperfusion/physiopathologie
11.
Transplant Proc ; 42(2): 451-3, 2010 Mar.
Article de Anglais | MEDLINE | ID: mdl-20304162

RÉSUMÉ

To study whether treatment with the beta-blocker atenolol (AT) attenuates intestinal dysfunction caused by ischemia (I) and reperfusion (R), rabbits were treated with AT (1 mg.kg(-1), introvenously) or saline solution (SS) prior to I (60 minutes), which was produced by occlusion of the superior mesenteric artery, and/or R (120 minutes). After I or I/R, 2-cm jejunal segments were mounted in an organ bath to study neurogenic contractions stimulated by electrical pulses or KCl using a digital recording system. Thin jejunal slices were stained hematoxylin and eosin for analysis by optical microscopy. Compared to the sham group, the jejunal contractions were similar in the I + AT and the I/R + AT groups, but reduced in the I + SS and the I/R + SS groups. The jejunal enteric nerves were damaged in the I + SS and the I/R + SS groups, but not in the I + AT and the I/R + AT. These results suggest that AT may attenuate intestinal dysfunction caused by I and I/R.


Sujet(s)
Aténolol/usage thérapeutique , Maladies intestinales/traitement médicamenteux , Intestins/vascularisation , Jéjunum/physiologie , Lésion d'ischémie-reperfusion/traitement médicamenteux , Animaux , Circulation sanguine , Stimulation électrique , Maladies intestinales/étiologie , Jéjunum/vascularisation , Jéjunum/effets des médicaments et des substances chimiques , Mâle , Artère mésentérique supérieure/physiologie , Contraction musculaire/effets des médicaments et des substances chimiques , Contraction musculaire/physiologie , Chlorure de potassium/pharmacologie , Lapins
12.
Transplant Proc ; 42(2): 454-6, 2010 Mar.
Article de Anglais | MEDLINE | ID: mdl-20304163

RÉSUMÉ

To study if the treatment with adenosine (ADO), an agonist of adenosine receptors, attenuates intestinal dysfunction caused by ischemia (I) and reperfusion (R), we treated rabbits with ADO (15 mg x kg(-1), intravenously) or saline solution (SS) to I (60 minutes) before occlusion of superior mesenteric artery and/or R (120 min). After I or I/R, isolated jejunal segments (2 cm) were mounted in an organ bath to study nerve-mediated contractions stimulated by electrical pulses or KCl using a digital recording system. Thin jejunal slices were stained (hematoxylin and eosin) for analysis by optical microscopy. Compared to the sham group, the jejunal contractions were similar in I + ADO, but reduced in I + SS, I/R + SS, and I/R + ADO groups. We concluded that the jejunal enteric nerves were damaged in I + SS, I/R + SS, and I/R + ADO, but not in I + ADO group. These results suggested that ADO attenuated intestinal dysfunction due to I, but not to R.


Sujet(s)
Adénosine/pharmacologie , Intestins/vascularisation , Lésion d'ischémie-reperfusion/traitement médicamenteux , Animaux , Circulation sanguine , Stimulation électrique , Veine fémorale/effets des médicaments et des substances chimiques , Veine fémorale/physiologie , Jéjunum/vascularisation , Jéjunum/effets des médicaments et des substances chimiques , Jéjunum/physiologie , Mâle , Artère mésentérique supérieure/physiologie , Contraction musculaire/effets des médicaments et des substances chimiques , Contraction musculaire/physiologie , Chlorure de potassium/pharmacologie , Agonistes des récepteurs purinergiques P1 , Lapins , Chlorure de sodium/pharmacologie
13.
Transplant Proc ; 42(2): 457-60, 2010 Mar.
Article de Anglais | MEDLINE | ID: mdl-20304164

RÉSUMÉ

To study whether treatment with L-nitro-arginine methyl ester (L-NAME), an inhibitor of nitric oxide biosynthesis, attenuates intestinal dysfunction caused by ischemia (I) and/or reperfusion (R), rabbits were treated with L-NAME (15 mgxkg(-1), intervenously) or saline olution (SS) prior to I (60 minutes) induced by occlusion of superior mesenteric artery and/or R (120 minutes). After I or I/R, isolated jejunal segments (2 cm) were mounted in an organ bath to study nerve-mediated contractions stimulated by electrical pulses or KCI using a digital recording system. Thin jejunal slices were stained (hematoxylin and eosin) for analysis by optical microscopy. Compared with a sham group, the jejunal contractions were similar in the I/R + L-NAME, but reduced in I + SS, I/R + SS, and I + L-NAME groups. The jejunal enteric nerves were damaged in the I + SS, I/R + SS, and I + L-NAME cohorts, but not among the I/R + L-NAME cohort. These results suggested that L-NAME attenuated intestinal dysfunction caused by R but not by I.


Sujet(s)
Motilité gastrointestinale/effets des médicaments et des substances chimiques , Maladies intestinales/prévention et contrôle , L-NAME/pharmacologie , Lésion d'ischémie-reperfusion/prévention et contrôle , Lésion d'ischémie-reperfusion/physiopathologie , Animaux , Stimulation électrique , Ischémie/physiopathologie , Jéjunum/effets des médicaments et des substances chimiques , Jéjunum/innervation , Jéjunum/physiologie , Mâle , Contraction musculaire/effets des médicaments et des substances chimiques , Contraction musculaire/physiologie , Lapins , Chlorure de sodium/pharmacologie
14.
Transplant Proc ; 42(2): 461-4, 2010 Mar.
Article de Anglais | MEDLINE | ID: mdl-20304165

RÉSUMÉ

To study whether treatment with 5'-adenosine triphosphate (ATP), an agonist of P2 purine receptors, attenuated intestinal dysfunction caused by ischemia (I) and/or reperfusion (R), rabbits were treated with ATP (15 mgxkg(-1), intravenously) or saline solution (SS) 60 minutes before I by occlusion of the superior mesenteric artery and/or R (120 minutes). After I or I/R isolated 2-cm jejunal segments were mounted in an organ bath to study nerve-mediated contractions stimulated by electrical pulses or KCl using a digital recording system. Thin jejunal slices were stained (hematoxylin and eosin) for optical microscopy. Compared to a sham group, the jejunal contractions were similar to sham hosts among I + ATP, but reduced in I + SS, I/R + SS, and I/R + ATP groups. The jejunal-enteric nerves were damaged in I + SS, I/R + SS, and I/R + ATP, but not the I + ATP group. These results suggested that ATP attenuated intestinal dysfunction produced by I, but not that caused by R.


Sujet(s)
Adénosine triphosphate/pharmacologie , Intestins/vascularisation , Ischémie/physiopathologie , Jéjunum/vascularisation , Lésion d'ischémie-reperfusion/physiopathologie , Animaux , Circulation sanguine/effets des médicaments et des substances chimiques , Circulation sanguine/physiologie , Ischémie/traitement médicamenteux , Jéjunum/effets des médicaments et des substances chimiques , Jéjunum/innervation , Mâle , Artère mésentérique supérieure/effets des médicaments et des substances chimiques , Artère mésentérique supérieure/physiopathologie , Lapins , Chlorure de sodium/pharmacologie
15.
Transplant Proc ; 41(3): 807-11, 2009 Apr.
Article de Anglais | MEDLINE | ID: mdl-19376358

RÉSUMÉ

In this work, we evaluate the effects of adenosine 5' triphosphate (ATP) on hepatic lesions caused by ischemia/reperfusion (I/R) in liver rabbit. Rabbits were pretreated with ATP (15 mg/kg IV) or saline solution 0.9% (SS), before the hepatic I/R procedure. We evaluated the effects of ATP on hepatic injury before and after I/R. The warm hepatic I/R procedure caused profound acute liver injury, as indicated by elevated serum aspartate aminotransferase, alanine aminotransferase, and lactic dehydrogenase levels, as well as a high apoptotic cell count. All these changes were attenuate by ATP treatment before the hepatic I/R procedure. These results suggested that ATP exerted protective effects on hepatic I/R lesions in the rabbit. This ATP effect may be related to improved energy metabolism during reperfusion in ischemic livers protecting against functional damage of cellular and subcellular membranes during lipid peroxidation.


Sujet(s)
Maladies du foie/physiopathologie , Purines/métabolisme , Lésion d'ischémie-reperfusion/physiopathologie , Adénosine triphosphate/usage thérapeutique , Alanine transaminase/effets des médicaments et des substances chimiques , Alanine transaminase/métabolisme , Animaux , Aspartate aminotransferases/effets des médicaments et des substances chimiques , Aspartate aminotransferases/métabolisme , Ischémie/physiopathologie , L-Lactate dehydrogenase/effets des médicaments et des substances chimiques , L-Lactate dehydrogenase/métabolisme , Foie/effets des médicaments et des substances chimiques , Foie/physiopathologie , Maladies du foie/prévention et contrôle , Mâle , Mitochondries du foie/effets des médicaments et des substances chimiques , Mitochondries du foie/métabolisme , Lapins , Lésion d'ischémie-reperfusion/prévention et contrôle
16.
Transplant Proc ; 41(3): 816-9, 2009 Apr.
Article de Anglais | MEDLINE | ID: mdl-19376360

RÉSUMÉ

We evaluated the effects of a substrate in the biosynthesis of nitric oxide (NO)-l-arginine (LARG)-on hepatic lesions caused by ischemia/reperfusion (I/R) injury in rabbit livers. Rabbits were pretreated with LARG (150 mg/kg IV) or saline solution 0.9% (SS) before the hepatic I/R procedure. The effects of LARG on hepatic injury were evaluated before and after I/R. The warm hepatic I/R procedure produced profound acute liver injury, as indicated by elevated values of serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactic dehydrogenase (LDH), as well as a high apoptotic cell count. All changes were attenuated by treatment with LARG before the hepatic I/R procedure. These results suggested that LARG produced protective effects on hepatic I/R lesions. This protective effect of LARG was probably associated with blocking generation of superoxide anions during the hepatic I/R procedure.


Sujet(s)
Arginine/usage thérapeutique , Maladies du foie/prévention et contrôle , Lésion d'ischémie-reperfusion/prévention et contrôle , Alanine transaminase/sang , Alanine transaminase/effets des médicaments et des substances chimiques , Animaux , Aspartate aminotransferases/sang , Aspartate aminotransferases/effets des médicaments et des substances chimiques , L-Lactate dehydrogenase/sang , L-Lactate dehydrogenase/effets des médicaments et des substances chimiques , Circulation hépatique/effets des médicaments et des substances chimiques , Mâle , Monoxyde d'azote/métabolisme , Lapins , Lésion d'ischémie-reperfusion/enzymologie , Lésion d'ischémie-reperfusion/anatomopathologie , Vasoconstriction/effets des médicaments et des substances chimiques
17.
Transplant Proc ; 41(3): 812-5, 2009 Apr.
Article de Anglais | MEDLINE | ID: mdl-19376359

RÉSUMÉ

Because the role of heparin (HEP) in hepatic ischemia/reperfusion (I/R) injury is still not fully understood, we investigated the effects of treatment with HEP on hepatic I/R injury in rabbits. For I/R procedures, the portal vein and hepatic artery were occluded by a metallic clamp to promote ischemia. The clamp was removed after 30 minutes to allow reperfusion. Rabbits undergoing the I/R procedure were treated with HEP (100 U/kg) or saline solution 0.9% (SS). When compared with levels before I/R, the serum aspartate aminotransferase, alanine aminotransferase, and lactate dehydrogenase, levels were increased by the hepatic I/R procedure, among rabbits treated with SS or HEP. However, the increase in these enzymes was lower among rabbits treated with HEP. Histologic analysis of hepatic tissue of rabbits undergoing I/R and treated with SS showed marked lesions in the central lobule with significant inflammatory infiltration. In contrast, a significant reduction in lesions caused by I/R was observed in the livers of rabbits treated with HEP. After starting reperfusion, we visualized apoptotic cells with nuclear staining among rabbits submitted to I/R and treated with SS, but not those treated with HEP. These results suggested that HEP was able to attenuate hepatic lesions caused by I/R in the livers of rabbits.


Sujet(s)
Héparine/usage thérapeutique , Ischémie/traitement médicamenteux , Maladies du foie/traitement médicamenteux , Lésion d'ischémie-reperfusion/prévention et contrôle , Alanine transaminase/effets des médicaments et des substances chimiques , Alanine transaminase/métabolisme , Animaux , Aspartate aminotransferases/effets des médicaments et des substances chimiques , Aspartate aminotransferases/métabolisme , Modèles animaux de maladie humaine , Fibrinolytiques/usage thérapeutique , Ischémie/enzymologie , L-Lactate dehydrogenase/effets des médicaments et des substances chimiques , L-Lactate dehydrogenase/métabolisme , Foie/enzymologie , Maladies du foie/enzymologie , Mâle , Lapins , Lésion d'ischémie-reperfusion/enzymologie
18.
Transplant Proc ; 41(3): 820-3, 2009 Apr.
Article de Anglais | MEDLINE | ID: mdl-19376361

RÉSUMÉ

In this work, we evaluated the effects of allopurinol (ALO), an inhibitor of xanthine oxidase (XO), on hepatic lesions caused by ischemia/reperfusion (I/R) in the rabbit liver. Rabbits were pretreated with ALO (10 mg/kg IV) or saline solution 0.9% before the hepatic I/R procedure. The effects of ALO on hepatic injury were evaluated before and after I/R. A standard, warm hepatic I/R procedure caused profound acute liver injury, as indicated by elevated serum aspartate aminotransferase, alanine aminotransferase, and lactic dehydrogenase levels, as well as a high apoptotic cell count. All of these changes were reversed by the administration of ALO before the hepatic I/R procedure. In conclusion, ALO exerted protective effects on hepatic I/R lesions. This protective effect of ALO was probably associated with blocking the generation of superoxide anions during the hepatic I/R procedure by inhibiting XO activity.


Sujet(s)
Allopurinol/usage thérapeutique , Maladies du foie/prévention et contrôle , Lésion d'ischémie-reperfusion/prévention et contrôle , Alanine transaminase/sang , Alanine transaminase/effets des médicaments et des substances chimiques , Animaux , Aspartate aminotransferases/sang , Aspartate aminotransferases/effets des médicaments et des substances chimiques , Antienzymes/usage thérapeutique , L-Lactate dehydrogenase/sang , L-Lactate dehydrogenase/effets des médicaments et des substances chimiques , Mâle , Lapins , Xanthine oxidase/antagonistes et inhibiteurs
19.
Transplant Proc ; 41(3): 824-6, 2009 Apr.
Article de Anglais | MEDLINE | ID: mdl-19376362

RÉSUMÉ

BACKGROUND: Previous studies have suggested that the addition of heparin to a preservation solution attenuated the autonomic dysfunction observed in rat jejunum and in addition that hypothermic hyperbaric oxygenation may play a role as a preservation technique. However, these studies did not address the lesion indices of the autonomic enteric neurons. We sought to investigate whether the autonomic enteric neurons are injured during cold ischemic preservation and whether administration of heparin or hyperbaric oxygenation prevents this lesion. METHODS: Jejunal segments (2 cm; n = 20) of Wistar rats (12-16 weeks old) were maintained in lactated Ringer's solution without or with heparin (H- and H+, respectively) at 4 degrees C under normobaric conditions. Other jejunal segments (n = 10) were maintained at 4 degrees C in H- under hyperbaric oxygenation conditions (HBO). After preservation for 12 hours, H-, H+, and HBO preparations fixed in 10% formaldehyde were stained with hematoxylin and eosin. The lesion indices were expressed as the mean number of affected neurons (karyorhexis, nuclear dislocation, cytoplasmic vacuolisation) per 100 neurons present in intramural ganglia. Statistical analysis was performed using the Mann-Whitney test (P < .05). RESULTS: The histologic studies showed that enteric autonomic neurons were damaged in H- jejunal segments. The lesion indices observed were: karyorhexis 90/100, nuclear dislocation 85/100, and cytoplasmic vacuolization 82/100. The autonomic neurons in H+ and HBO segments seemed to be normal and significantly well-preserved (P < .001). CONCLUSION: Hypothermic hyperbaric oxygenation and heparin prevented lesions in cold ischemic preservation of enteric autonomic neurons.


Sujet(s)
Héparine/usage thérapeutique , Oxygénation hyperbare , Neurones/physiologie , Conservation d'organe/méthodes , Lésion d'ischémie-reperfusion/prévention et contrôle , Animaux , Système nerveux autonome/effets des médicaments et des substances chimiques , Système nerveux autonome/physiologie , Noyau de la cellule/effets des médicaments et des substances chimiques , Noyau de la cellule/physiologie , Cytoplasme/effets des médicaments et des substances chimiques , Cytoplasme/physiologie , Jéjunum/effets des médicaments et des substances chimiques , Jéjunum/innervation , Mâle , Neurones/cytologie , Neurones/effets des médicaments et des substances chimiques , Rats , Rat Wistar , Vacuoles/effets des médicaments et des substances chimiques , Vacuoles/physiologie
20.
Age (Dordr) ; 31(1): 51-8, 2009 Mar.
Article de Anglais | MEDLINE | ID: mdl-19234768

RÉSUMÉ

The effects of carbachol and atropine on the number of trains (NT) and on the train stimulus strength (SS) necessary to induce arrhythmia were studied in isolated right atria of infant, young, adult and mature rats submitted to electric field stimulation (66.7 Hz, 5 ms pulse-duration, 250 pulses). Carbachol (1 microM) decreased NT from four (control) to two in all ages tested. Atropine (1 microM) prevented tachyarrhythmia induction in tissue of all ages, even with NT equal to 12, except for mature rats (typically four trains). The SS decreases from infant to adult age [5- to 2-fold atrial threshold (AT)] and increases in mature animals (5-fold AT). Carbachol changes this result only for mature rats (5- to 2-fold AT). The SS was decreased by carbachol (1 microM) from 5- to 3-fold AT in mature rats, but atropine did not modify SS in this age. These results indicate that inducibility and cholinergic modulation of atrial tachyarrhythmia is influenced by age.

SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE